Medical Supply Chains: Questions Companies are Asking and Evolving Government Actions in the Aftermath of COVID-19
Webinar | 06.24.20, 7:00 AM EDT - 8:00 AM EDT
Supply chains have been upended in the wake of COVID-19. Companies have configured medical supply chains for cost, efficiency and competitive advantage. Governments are challenging these assumptions. U.S. officials have called for “re-shoring” supply chains, using new tariffs and subsidies for medical equipment, pharmaceuticals, and PPE. American, European and Asian governments are looking to use their purchasing power, new laws and regulations, and trade agreements to alter global supply relationships. This webinar will provide insights across a series of topics, including:
- What does “resiliency” mean for supply chains in the COVID-19?;
- Export restrictions imposed as a consequence of COVID-19;
- Prospects for nationalizing production and procurement requirements;
- Possible subsidies and tax incentives for “re-shoring” efforts;
- Regulatory barriers and obstacles to reconfiguration;
- Trusted trading partner supply chain networks; and
- The role of national and international institutions.
For more information, please visit these areas: Crowell Global Advisors
Contact
Insights
Webinar | 12.10.26
The Third-Party Perspective: Protecting Payors’ Interests in Antitrust Investigations
The Trump administration has sharpened its focus on hospital systems as a key driver of rising health care costs, and the DOJ and FTC are actively patrolling for anticompetitive conduct and mergers that contribute to these rising costs. Managed care organizations are a critical source of evidence in these investigations and are likely to receive Civil Investigative Demands (CIDs), be contacted by agency staff, or may consider proactively engaging with antitrust authorities to address competitive concerns in their markets.
Webinar | 11.17.26
